Journal
Annals of Clinical and Translational Neurology
Publication Date
2018
Volume
5
Issue
12
Inclusive Pages
1492-1504
Document Type
Open Access Publication
DOI
10.1002/acn3.657
Rights and Permissions
Self, W. K., Schoch, K. M., Alex, J. , Barthélemy, N. , Bollinger, J. G., Sato, C. , Cole, T. , Kordasiewicz, H. B., Swayze, E. , Bateman, R. J. and Miller, T. M. (2018), Protein production is an early biomarker for RNA‐targeted therapies. Ann Clin Transl Neurol, 5: 1492-1504. doi:10.1002/acn3.657 Copyright 2018 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Recommended Citation
Self, Wade K.; Schoch, Kathleen M.; Alex, Jacob; Barthélemy, Nicolas; Bollinger, James G.; Sato, Chihiro; Cole, Tracy; Kordasiewicz, Holly B.; Swayze, Eric; Bateman, Randall J.; and Miller, Timothy M., "Protein production is an early biomarker for RNA‐targeted therapies." Annals of Clinical and Translational Neurology. 5, 12. 1492-1504. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7385
